↓ Skip to main content

Optimization of culture conditions for rapid clinical‐scale expansion of human umbilical cord blood‐derived mesenchymal stem cells

Overview of attention for article published in Clinical and Translational Medicine, October 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
9 X users
patent
14 patents
facebook
1 Facebook page

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
31 Mendeley
Title
Optimization of culture conditions for rapid clinical‐scale expansion of human umbilical cord blood‐derived mesenchymal stem cells
Published in
Clinical and Translational Medicine, October 2017
DOI 10.1186/s40169-017-0168-z
Pubmed ID
Authors

Wankyu Choi, Soon-Jae Kwon, Hye Jin Jin, Sang Young Jeong, Soo Jin Choi, Wonil Oh, Yoon Sun Yang, Hong Bae Jeon, Eun Su Jeon

Abstract

Mesenchymal stem cells (MSCs) have broad-spectrum therapeutic effects in various diseases, and thus have many clinical applications. However, it is difficult to produce sufficient numbers of MSCs for clinical use, and improved culture systems are required. Here, we report the effects of calcium (Ca(2+)) and hypoxia on the proliferation of human umbilical cord blood-derived MSCs (hUCB-MSCs). In addition, we determined the optimal conditions of these two factors for the large-scale culture of hUCB-MSCs. hUCB-MSCs were maintained under hypoxic conditions (3% O2) with 1.8 mM Ca(2+) during long-term culture, and their proliferation was evaluated. To characterize the underlying mechanisms, the effects on hypoxia-inducible factor (HIF)-1α and the extracellular signal-regulated kinase (ERK) signaling pathways were investigated. The therapeutic effects in a mouse emphysema model were analyzed and compared with those of naive MSCs. The proliferation of Ca(2+)/hypoxia-treated hUCB-MSCs was increased compared with that observed using either calcium or hypoxia culture alone, without loss of stem cell marker expression or differentiation ability. The enhancement of the proliferation capacity of hUCB-MSCs by the synergistic effects of Ca(2+) and hypoxia was dependent on the expression of HIF-1α and the ERK signaling pathway. The proliferation of Ca(2+)/hypoxia-treated hUCB-MSCs resulted in a delayed senescence phenotype and increased the expression levels of stemness genes such as Oct4 and Nanog compared to those observed in conventional culture conditions. In addition, Ca(2+)/hypoxia-treated MSCs transplantation in the mouse emphysema model showed the same therapeutic effects as observed with naive MSCs. These findings suggest that a Ca(2+)/hypoxia-based expansion system has applications for the large-scale production of MSCs for therapeutic purposes.

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 19%
Student > Bachelor 4 13%
Student > Master 4 13%
Student > Ph. D. Student 3 10%
Student > Doctoral Student 2 6%
Other 4 13%
Unknown 8 26%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 32%
Agricultural and Biological Sciences 5 16%
Medicine and Dentistry 3 10%
Chemical Engineering 1 3%
Immunology and Microbiology 1 3%
Other 1 3%
Unknown 10 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2023.
All research outputs
#3,059,016
of 25,756,531 outputs
Outputs from Clinical and Translational Medicine
#117
of 1,080 outputs
Outputs of similar age
#54,622
of 334,781 outputs
Outputs of similar age from Clinical and Translational Medicine
#1
of 10 outputs
Altmetric has tracked 25,756,531 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,080 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 10.0. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 334,781 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them